Cargando…
d-serine levels in Alzheimer's disease: implications for novel biomarker development
Alzheimer's disease (AD) is a severe neurodegenerative disorder still in search of effective methods of diagnosis. Altered levels of the NMDA receptor co-agonist, d-serine, have been associated with neurological disorders, including schizophrenia and epilepsy. However, whether d-serine levels a...
Autores principales: | Madeira, C, Lourenco, M V, Vargas-Lopes, C, Suemoto, C K, Brandão, C O, Reis, T, Leite, R E P, Laks, J, Jacob-Filho, W, Pasqualucci, C A, Grinberg, L T, Ferreira, S T, Panizzutti, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471283/ https://www.ncbi.nlm.nih.gov/pubmed/25942042 http://dx.doi.org/10.1038/tp.2015.52 |
Ejemplares similares
-
Elevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of Patients With Probable Alzheimer's Disease and Depression
por: Madeira, Caroline, et al.
Publicado: (2018) -
The effect of D-serine administration on cognition and mood in older adults
por: Avellar, Marcos, et al.
Publicado: (2016) -
African ancestry protects against Alzheimer's disease-related neuropathology
por: Schlesinger, D, et al.
Publicado: (2013) -
Pathophysiology of sepsis-associated brain dysfunction: an experimental study of cerebral microdialysis and mitochondrial function
por: Kurtz, P, et al.
Publicado: (2013) -
Do Copy Number Changes in CACNA2D2, CACNA2D3, and CACNA1D Constitute a Predisposing Risk Factor for Alzheimer’s Disease?
por: Villela, Darine, et al.
Publicado: (2016)